Telomerase expression in lung preneoplasia and neoplasia. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue International Journal of Cancer Année : 2007

Telomerase expression in lung preneoplasia and neoplasia.

Résumé

Telomeres are specialized structures at eukaryotic chromosomes ends, which role is to prevent them from degradation, end to-end fusion and rearrangement. However, they shorten after each cellular division because of an incomplete DNA replication, acting in normal somatic cells as a mitotic clock for permanent proliferation arrest or senescence entry. Short telomeres are perceived as damaged DNA leading to p53/ATM pathway activation. In tumoral cells, a ribonucleoprotein complex termed telomerase enables telomere elongation. This complex, composed of 2 main components, the telomerase RNA component or hTR, the RNA template for telomere synthesis, and telomerase reverse transcriptase, the catalytic subunit, is reactivated in the majority of cancers, including those of the lung. In this review, we briefly present the main results on telomerase expression in various histological types of lung carcinoma and in bronchial carcinogenesis along with telomere attrition. Inhibition of one of the main components of the enzyme or limitation of telomere access by telomerase represent novel targets for cancer therapies and chemoprevention in high risk patients of lung cancer.

Domaines

Cancer

Dates et versions

inserm-00173051 , version 1 (18-09-2007)

Identifiants

Citer

Sylvie Lantuéjoul, Caroline Salon, Jean-Charles Soria, Elisabeth Brambilla. Telomerase expression in lung preneoplasia and neoplasia.. International Journal of Cancer, 2007, 120 (9), pp.1835-41. ⟨10.1002/ijc.22473⟩. ⟨inserm-00173051⟩

Collections

INSERM CEA U823
31 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More